Clinical trial
Oliceridine in Patients With Acute Burn Injuries
NCT05465226
Study timeline
Study start (actual)2023-04-01Date precision: day
Registry last updated2023-10-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Acute Painunresolved
Burnsunresolved
Adverse Drug Eventunresolved
Respiratory Depressionunresolved
Nausea and Vomiting, Postoperativeunresolved
Interventions
OliceridineDRUG · verified · RxNorm: oliceridine
Sponsors & collaborators
University of Tennesseelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05465226 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.